Jailendra Singh
Stock Analyst at Truist Financial
(0.14)
# 4,536
Out of 4,630 analysts
759
Total ratings
42.6%
Success rate
-6.3%
Average return
Main Sectors:
Stocks Rated by Jailendra Singh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HIMS Hims & Hers Health | Reiterated: Hold | n/a | $32.03 | - | 60 | Aug 10, 2026 | |
| ASTH Astrana Health | Maintained: Buy | n/a | $37.55 | - | 30 | Aug 7, 2026 | |
| PGNY Progyny | Maintained: Buy | n/a | $28.48 | - | 46 | Aug 7, 2026 | |
| PRVA Privia Health Group | Maintained: Buy | n/a | $22.42 | - | 38 | Aug 7, 2026 | |
| DOCS Doximity | Reiterated: Hold | n/a | $25.60 | - | 29 | Aug 7, 2026 | |
| GDRX GoodRx Holdings | Maintained: Hold | n/a | $3.80 | - | 41 | Aug 6, 2026 | |
| AGL agilon health | Rated: Hold | $67 → $112 | $97.80 | +14.52% | 34 | Aug 6, 2026 | |
| BTMD biote | Maintained: Buy | n/a | $1.51 | - | 2 | Aug 6, 2026 | |
| MDLN Medline | Maintained: Buy | $47 | $33.86 | +38.81% | 7 | Aug 6, 2026 | |
| AMWL American Well | Maintained: Hold | n/a | $13.66 | - | 37 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $89.80 | - | 24 | Aug 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $207 → $209 | $164.92 | +26.73% | 36 | Jul 31, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $7.12 | - | 63 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $26 | $18.60 | +39.78% | 13 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $24.78 | - | 15 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $300 | $240.10 | +24.95% | 47 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $609 | $597.15 | +1.98% | 19 | Jul 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $7 | $4.15 | +68.88% | 52 | Jun 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $12.37 | - | 26 | Jun 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $262 | $233.80 | +12.06% | 35 | Jun 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $11.44 | - | 1 | Jun 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $116 | $205.90 | -43.66% | 2 | Feb 27, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $7.39 | - | 3 | Sep 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $8.97 | n/a | 1 | Jul 30, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $14.75 | n/a | 1 | Jul 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $66.44 | n/a | 1 | Jul 2, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $281.80 | n/a | 1 | May 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $397.44 | n/a | 1 | Apr 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $51.56 | n/a | 1 | Jan 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $1.31 | n/a | 1 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | n/a | $388.48 | n/a | 1 | Oct 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $9.53 | n/a | 1 | Sep 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $1.65 | n/a | 1 | Sep 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $1,213.40 | n/a | 1 | Jul 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $415.49 | n/a | 1 | Apr 29, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $21 → $22 | $39.65 | n/a | 2 | Apr 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $610 | $410.70 | n/a | 1 | Nov 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $31 → $16 | $1.33 | n/a | 19 | Mar 3, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $42 → $43 | $1.31 | n/a | 12 | Feb 28, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $30 → $24 | $0.7033 | n/a | 3 | Feb 24, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $14 → $4 | $0.707 | n/a | 9 | Feb 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $145 → $180 | $325.12 | n/a | 14 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $50 → $62 | $237.66 | n/a | 6 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $230 → $333 | $891.41 | n/a | 12 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $9 → $3.5 | $4.67 | n/a | 4 | Jan 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $26 → $21 | $28.43 | n/a | 4 | Nov 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 | $177.35 | n/a | 1 | Feb 26, 2020 |
Hims & Hers Health
Aug 10, 2026
Reiterated: Hold
Price Target: n/a
Current: $32.03
Upside: -
Astrana Health
Aug 7, 2026
Maintained: Buy
Price Target: n/a
Current: $37.55
Upside: -
Progyny
Aug 7, 2026
Maintained: Buy
Price Target: n/a
Current: $28.48
Upside: -
Privia Health Group
Aug 7, 2026
Maintained: Buy
Price Target: n/a
Current: $22.42
Upside: -
Doximity
Aug 7, 2026
Reiterated: Hold
Price Target: n/a
Current: $25.60
Upside: -
GoodRx Holdings
Aug 6, 2026
Maintained: Hold
Price Target: n/a
Current: $3.80
Upside: -
agilon health
Aug 6, 2026
Rated: Hold
Price Target: $67 → $112
Current: $97.80
Upside: +14.52%
biote
Aug 6, 2026
Maintained: Buy
Price Target: n/a
Current: $1.51
Upside: -
Medline
Aug 6, 2026
Maintained: Buy
Price Target: $47
Current: $33.86
Upside: +38.81%
American Well
Aug 5, 2026
Maintained: Hold
Price Target: n/a
Current: $13.66
Upside: -
Aug 5, 2026
Maintained: Buy
Price Target: n/a
Current: $89.80
Upside: -
Jul 31, 2026
Reiterated: Buy
Price Target: $207 → $209
Current: $164.92
Upside: +26.73%
Jul 30, 2026
Maintained: Hold
Price Target: n/a
Current: $7.12
Upside: -
Jul 30, 2026
Maintained: Buy
Price Target: $26
Current: $18.60
Upside: +39.78%
Jul 30, 2026
Maintained: Buy
Price Target: n/a
Current: $24.78
Upside: -
Jul 29, 2026
Reiterated: Buy
Price Target: $300
Current: $240.10
Upside: +24.95%
Jul 28, 2026
Maintained: Hold
Price Target: $609
Current: $597.15
Upside: +1.98%
Jun 30, 2026
Downgraded: Hold
Price Target: $7
Current: $4.15
Upside: +68.88%
Jun 12, 2026
Maintained: Hold
Price Target: n/a
Current: $12.37
Upside: -
Jun 4, 2026
Maintained: Buy
Price Target: $262
Current: $233.80
Upside: +12.06%
Jun 3, 2026
Reiterated: Buy
Price Target: n/a
Current: $11.44
Upside: -
Feb 27, 2026
Reiterated: Buy
Price Target: $116
Current: $205.90
Upside: -43.66%
Sep 4, 2025
Maintained: Buy
Price Target: n/a
Current: $7.39
Upside: -
Jul 30, 2025
Maintained: Hold
Price Target: n/a
Current: $8.97
Upside: n/a
Jul 17, 2025
Maintained: Buy
Price Target: n/a
Current: $14.75
Upside: n/a
Jul 2, 2025
Maintained: Buy
Price Target: n/a
Current: $66.44
Upside: n/a
May 5, 2025
Reiterated: Buy
Price Target: n/a
Current: $281.80
Upside: n/a
Apr 21, 2025
Reiterated: Buy
Price Target: n/a
Current: $397.44
Upside: n/a
Jan 13, 2025
Reiterated: Buy
Price Target: n/a
Current: $51.56
Upside: n/a
Nov 19, 2024
Maintained: Buy
Price Target: n/a
Current: $1.31
Upside: n/a
Oct 3, 2024
Rated: Hold
Price Target: n/a
Current: $388.48
Upside: n/a
Sep 9, 2024
Maintained: Hold
Price Target: n/a
Current: $9.53
Upside: n/a
Sep 4, 2024
Reiterated: Buy
Price Target: n/a
Current: $1.65
Upside: n/a
Jul 3, 2024
Maintained: Buy
Price Target: n/a
Current: $1,213.40
Upside: n/a
Apr 29, 2024
Reiterated: Buy
Price Target: n/a
Current: $415.49
Upside: n/a
Apr 16, 2024
Maintained: Hold
Price Target: $21 → $22
Current: $39.65
Upside: n/a
Nov 29, 2022
Reiterated: Buy
Price Target: $610
Current: $410.70
Upside: n/a
Mar 3, 2022
Maintained: Hold
Price Target: $31 → $16
Current: $1.33
Upside: n/a
Feb 28, 2022
Maintained: Hold
Price Target: $42 → $43
Current: $1.31
Upside: n/a
Feb 24, 2022
Maintained: Hold
Price Target: $30 → $24
Current: $0.7033
Upside: n/a
Feb 8, 2022
Downgraded: Hold
Price Target: $14 → $4
Current: $0.707
Upside: n/a
Jan 7, 2022
Maintained: Buy
Price Target: $145 → $180
Current: $325.12
Upside: n/a
Jan 7, 2022
Maintained: Hold
Price Target: $50 → $62
Current: $237.66
Upside: n/a
Jan 7, 2022
Upgraded: Buy
Price Target: $230 → $333
Current: $891.41
Upside: n/a
Jan 7, 2022
Downgraded: Sell
Price Target: $9 → $3.5
Current: $4.67
Upside: n/a
Nov 11, 2021
Maintained: Buy
Price Target: $26 → $21
Current: $28.43
Upside: n/a
Feb 26, 2020
Maintained: Buy
Price Target: $30
Current: $177.35
Upside: n/a